Mettler-Toledo International Inc. (NYSE:MTD) Shares Acquired by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. increased its stake in shares of Mettler-Toledo International Inc. (NYSE:MTDFree Report) by 29.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,196 shares of the medical instruments supplier’s stock after buying an additional 504 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in Mettler-Toledo International were worth $2,705,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the stock. Blue Trust Inc. grew its position in shares of Mettler-Toledo International by 242.9% during the third quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock worth $34,000 after acquiring an additional 17 shares during the last quarter. Ashton Thomas Securities LLC acquired a new position in Mettler-Toledo International during the 3rd quarter valued at about $37,000. Sound Income Strategies LLC grew its position in Mettler-Toledo International by 4,500.0% in the 4th quarter. Sound Income Strategies LLC now owns 46 shares of the medical instruments supplier’s stock worth $56,000 after purchasing an additional 45 shares during the last quarter. Raleigh Capital Management Inc. increased its stake in shares of Mettler-Toledo International by 272.7% in the third quarter. Raleigh Capital Management Inc. now owns 41 shares of the medical instruments supplier’s stock valued at $61,000 after purchasing an additional 30 shares during the period. Finally, Whittier Trust Co. of Nevada Inc. raised its holdings in shares of Mettler-Toledo International by 60.0% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 48 shares of the medical instruments supplier’s stock valued at $72,000 after buying an additional 18 shares during the last quarter. 95.07% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, insider Gerry Keller sold 140 shares of Mettler-Toledo International stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total value of $175,572.60. Following the transaction, the insider now directly owns 6 shares of the company’s stock, valued at $7,524.54. This trade represents a 95.89 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 1.94% of the company’s stock.

Mettler-Toledo International Trading Up 2.4 %

Shares of NYSE MTD opened at $1,390.00 on Monday. Mettler-Toledo International Inc. has a twelve month low of $1,133.46 and a twelve month high of $1,546.93. The company has a market capitalization of $29.33 billion, a price-to-earnings ratio of 34.30, a PEG ratio of 4.80 and a beta of 1.13. The firm has a 50-day moving average of $1,278.92 and a two-hundred day moving average of $1,343.25.

Mettler-Toledo International (NYSE:MTDGet Free Report) last released its earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 EPS for the quarter, beating the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 564.51%. As a group, research analysts predict that Mettler-Toledo International Inc. will post 41.94 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts recently issued reports on MTD shares. Robert W. Baird decreased their price objective on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a report on Monday, November 11th. Wells Fargo & Company lowered their price target on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a report on Monday, November 11th. Evercore ISI raised shares of Mettler-Toledo International from an “in-line” rating to an “outperform” rating and upped their price objective for the stock from $1,375.00 to $1,450.00 in a report on Thursday, January 2nd. Citigroup raised shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and raised their target price for the company from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. Finally, Wolfe Research started coverage on shares of Mettler-Toledo International in a research note on Friday, December 13th. They set a “peer perform” rating on the stock. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $1,351.25.

View Our Latest Report on Mettler-Toledo International

Mettler-Toledo International Profile

(Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Recommended Stories

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.